Terry Ann Burrell Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity
Terry Ann Burrell is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 71,254 shares of RXRX, which is worth approximately $505,903. The most recent transaction as insider was on Jul 01, 2024, when has been sold 1,843 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
71.3K
0%
3M change
29.91%
12M change
Total Value Held
$505,903
Terry-Ann Burrell Transaction History
Also insider at
TB
Terry Ann Burrell
Director
Cambridge, MA